Timothy Shaw - 01 Mar 2026 Form 4 Insider Report for MARIMED INC. (MRMD)

Role: Chief Operating Officer
Signature: /s/ Timothy Shaw
Issuer symbol: MRMD
Transactions as of: 01 Mar 2026
Net transactions value: -$1,910
Form type: 4
Filing time: 02 Mar 2026, 16:12:20 UTC
Previous filing: 16 Dec 2025
Next filing: 09 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Shaw Timothy	Chief Operating Officer	C/O MARIMED INC., 10 OCEANA WAY, NORWOOD,	/s/ Timothy Shaw	02 Mar 2026	0001866577

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRMD	Common stock	Options Exercise	$0	+65,000	+0.7%	$0.000000	9,359,541	01 Mar 2026	Direct	F1
transaction	MRMD	Common stock	Tax liability	$1,910	-22,523	-0.24%	$0.0848	9,337,018	01 Mar 2026	Direct	F2
holding	MRMD	Common stock						2,000,000	01 Mar 2026	By the Shaw Family Trust	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRMD	Restricted Stock Units (RSU)	Options Exercise	$0	-65,000	-50%	$0.000000	65,000	01 Mar 2026	Common Stock, par value $.001 per share	65,000		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	RSUs convert to shares of common stock on a one-for-one basis.
F2	Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
F3	The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4	These RSUs were granted on September 1, 2023; the remaining RSUs under this grant will vest on September 1, 2026 in accordance with the terms of an award agreement between the Issuer and the Reporting Person.